カテゴリー： Market Monitor Global, 世界, 医療/バイオ

処方鎮痛薬の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Pain Medications Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8598 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：77 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Pain Medications Market 調査レポートは次の情報を含め、グローバルにおけるの処方鎮痛薬市場規模と予測を収録しています。・世界の処方鎮痛薬市場：売上、2018年-2023年、2024年-2029年
・世界の処方鎮痛薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の処方鎮痛薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「処方薬 NSAIDs」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

処方鎮痛薬のグローバル主要企業は、Pfizer、 GSK、 Grunenthal、 Bayer、 Sanofi、 Eli Lilly、 AstraZeneca、 Endo、 Merck、 Depomed、 Teva、 J&J、 Allerganなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、処方鎮痛薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の処方鎮痛薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の処方鎮痛薬市場：タイプ別市場シェア、2022年
・処方薬 NSAIDs、オピオイド、抗てんかん薬、抗うつ薬、その他

世界の処方鎮痛薬市場：用途別、2018年-2023年、2024年-2029年
世界の処方鎮痛薬市場：用途別市場シェア、2022年
・病院、診療所、ドラッグストア、その他

世界の処方鎮痛薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の処方鎮痛薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における処方鎮痛薬のグローバル売上、2018年-2023年
・主要企業における処方鎮痛薬のグローバル売上シェア、2022年
・主要企業における処方鎮痛薬のグローバル販売量、2018年-2023年
・主要企業における処方鎮痛薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 GSK、 Grunenthal、 Bayer、 Sanofi、 Eli Lilly、 AstraZeneca、 Endo、 Merck、 Depomed、 Teva、 J&J、 Allergan

*************************************************************

・調査・分析レポートの概要
処方鎮痛薬市場の定義
市場セグメント
世界の処方鎮痛薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の処方鎮痛薬市場規模
世界の処方鎮痛薬市場規模：2022年 VS 2029年
世界の処方鎮痛薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの処方鎮痛薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の処方鎮痛薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：処方薬 NSAIDs、オピオイド、抗てんかん薬、抗うつ薬、その他
処方鎮痛薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、ドラッグストア、その他
処方鎮痛薬の用途別グローバル売上・予測

・地域別市場分析
地域別処方鎮痛薬市場規模 2022年と2029年
地域別処方鎮痛薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 GSK、 Grunenthal、 Bayer、 Sanofi、 Eli Lilly、 AstraZeneca、 Endo、 Merck、 Depomed、 Teva、 J&J、 Allergan
...

This report aims to provide a comprehensive presentation of the global market for Prescription Pain Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Pain Medications. This report contains market size and forecasts of Prescription Pain Medications in global, including the following market information:
Global Prescription Pain Medications Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Pain Medications Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Pain Medications companies in 2022 (%)
The global Prescription Pain Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prescription NSAIDs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Pain Medications include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Pain Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Pain Medications Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, by Type, 2022 (%)
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others
Global Prescription Pain Medications Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Drugstores
Others
Global Prescription Pain Medications Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Pain Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Pain Medications revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Pain Medications revenues share in global market, 2022 (%)
Key companies Prescription Pain Medications sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Pain Medications sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
J&J
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Pain Medications, market overview.
Chapter 2: Global Prescription Pain Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Pain Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Pain Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Pain Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Pain Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Pain Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Pain Medications Overall Market Size
2.1 Global Prescription Pain Medications Market Size: 2022 VS 2029
2.2 Global Prescription Pain Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Pain Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Pain Medications Players in Global Market
3.2 Top Global Prescription Pain Medications Companies Ranked by Revenue
3.3 Global Prescription Pain Medications Revenue by Companies
3.4 Global Prescription Pain Medications Sales by Companies
3.5 Global Prescription Pain Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Pain Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Pain Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Pain Medications Players in Global Market
3.8.1 List of Global Tier 1 Prescription Pain Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Pain Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Pain Medications Market Size Markets, 2022 & 2029
4.1.2 Prescription NSAIDs
4.1.3 Opioids
4.1.4 Anti-epileptic Medicines
4.1.5 Antidepressants
4.1.6 Others
4.2 By Type – Global Prescription Pain Medications Revenue & Forecasts
4.2.1 By Type – Global Prescription Pain Medications Revenue, 2018-2023
4.2.2 By Type – Global Prescription Pain Medications Revenue, 2024-2029
4.2.3 By Type – Global Prescription Pain Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Pain Medications Sales & Forecasts
4.3.1 By Type – Global Prescription Pain Medications Sales, 2018-2023
4.3.2 By Type – Global Prescription Pain Medications Sales, 2024-2029
4.3.3 By Type – Global Prescription Pain Medications Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Pain Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Pain Medications Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Drugstores
5.1.5 Others
5.2 By Application – Global Prescription Pain Medications Revenue & Forecasts
5.2.1 By Application – Global Prescription Pain Medications Revenue, 2018-2023
5.2.2 By Application – Global Prescription Pain Medications Revenue, 2024-2029
5.2.3 By Application – Global Prescription Pain Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Pain Medications Sales & Forecasts
5.3.1 By Application – Global Prescription Pain Medications Sales, 2018-2023
5.3.2 By Application – Global Prescription Pain Medications Sales, 2024-2029
5.3.3 By Application – Global Prescription Pain Medications Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Pain Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Pain Medications Market Size, 2022 & 2029
6.2 By Region – Global Prescription Pain Medications Revenue & Forecasts
6.2.1 By Region – Global Prescription Pain Medications Revenue, 2018-2023
6.2.2 By Region – Global Prescription Pain Medications Revenue, 2024-2029
6.2.3 By Region – Global Prescription Pain Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Pain Medications Sales & Forecasts
6.3.1 By Region – Global Prescription Pain Medications Sales, 2018-2023
6.3.2 By Region – Global Prescription Pain Medications Sales, 2024-2029
6.3.3 By Region – Global Prescription Pain Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Pain Medications Revenue, 2018-2029
6.4.2 By Country – North America Prescription Pain Medications Sales, 2018-2029
6.4.3 US Prescription Pain Medications Market Size, 2018-2029
6.4.4 Canada Prescription Pain Medications Market Size, 2018-2029
6.4.5 Mexico Prescription Pain Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Pain Medications Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Pain Medications Sales, 2018-2029
6.5.3 Germany Prescription Pain Medications Market Size, 2018-2029
6.5.4 France Prescription Pain Medications Market Size, 2018-2029
6.5.5 U.K. Prescription Pain Medications Market Size, 2018-2029
6.5.6 Italy Prescription Pain Medications Market Size, 2018-2029
6.5.7 Russia Prescription Pain Medications Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Pain Medications Market Size, 2018-2029
6.5.9 Benelux Prescription Pain Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Pain Medications Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Pain Medications Sales, 2018-2029
6.6.3 China Prescription Pain Medications Market Size, 2018-2029
6.6.4 Japan Prescription Pain Medications Market Size, 2018-2029
6.6.5 South Korea Prescription Pain Medications Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Pain Medications Market Size, 2018-2029
6.6.7 India Prescription Pain Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Pain Medications Revenue, 2018-2029
6.7.2 By Country – South America Prescription Pain Medications Sales, 2018-2029
6.7.3 Brazil Prescription Pain Medications Market Size, 2018-2029
6.7.4 Argentina Prescription Pain Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Pain Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Pain Medications Sales, 2018-2029
6.8.3 Turkey Prescription Pain Medications Market Size, 2018-2029
6.8.4 Israel Prescription Pain Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Pain Medications Market Size, 2018-2029
6.8.6 UAE Prescription Pain Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Prescription Pain Medications Major Product Offerings
7.1.4 Pfizer Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Prescription Pain Medications Major Product Offerings
7.2.4 GSK Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Grunenthal
7.3.1 Grunenthal Company Summary
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Prescription Pain Medications Major Product Offerings
7.3.4 Grunenthal Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.3.5 Grunenthal Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Prescription Pain Medications Major Product Offerings
7.4.4 Bayer Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Prescription Pain Medications Major Product Offerings
7.5.4 Sanofi Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Company Summary
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Prescription Pain Medications Major Product Offerings
7.6.4 Eli Lilly Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.6.5 Eli Lilly Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Prescription Pain Medications Major Product Offerings
7.7.4 AstraZeneca Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Endo
7.8.1 Endo Company Summary
7.8.2 Endo Business Overview
7.8.3 Endo Prescription Pain Medications Major Product Offerings
7.8.4 Endo Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.8.5 Endo Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Prescription Pain Medications Major Product Offerings
7.9.4 Merck Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 Depomed
7.10.1 Depomed Company Summary
7.10.2 Depomed Business Overview
7.10.3 Depomed Prescription Pain Medications Major Product Offerings
7.10.4 Depomed Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.10.5 Depomed Key News & Latest Developments
7.11 Teva
7.11.1 Teva Company Summary
7.11.2 Teva Prescription Pain Medications Business Overview
7.11.3 Teva Prescription Pain Medications Major Product Offerings
7.11.4 Teva Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.11.5 Teva Key News & Latest Developments
7.12 J&J
7.12.1 J&J Company Summary
7.12.2 J&J Prescription Pain Medications Business Overview
7.12.3 J&J Prescription Pain Medications Major Product Offerings
7.12.4 J&J Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.12.5 J&J Key News & Latest Developments
7.13 Allergan
7.13.1 Allergan Company Summary
7.13.2 Allergan Prescription Pain Medications Business Overview
7.13.3 Allergan Prescription Pain Medications Major Product Offerings
7.13.4 Allergan Prescription Pain Medications Sales and Revenue in Global (2018-2023)
7.13.5 Allergan Key News & Latest Developments
8 Global Prescription Pain Medications Production Capacity, Analysis
8.1 Global Prescription Pain Medications Production Capacity, 2018-2029
8.2 Prescription Pain Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Pain Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Pain Medications Supply Chain Analysis
10.1 Prescription Pain Medications Industry Value Chain
10.2 Prescription Pain Medications Upstream Market
10.3 Prescription Pain Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Pain Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Pain Medications in Global Market
Table 2. Top Prescription Pain Medications Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Pain Medications Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Pain Medications Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Pain Medications Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Pain Medications Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Pain Medications Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Prescription Pain Medications Product Type
Table 9. List of Global Tier 1 Prescription Pain Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Pain Medications Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Pain Medications Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Pain Medications Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Pain Medications Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Pain Medications Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Pain Medications Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Pain Medications Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Pain Medications Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Pain Medications Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Pain Medications Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Pain Medications Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Pain Medications Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Pain Medications Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Pain Medications Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Pain Medications Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Pain Medications Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Pain Medications Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Pain Medications Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Pain Medications Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Pain Medications Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Pain Medications Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Pain Medications Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Pain Medications Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Pain Medications Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Pain Medications Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Pain Medications Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Pain Medications Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Pain Medications Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Pain Medications Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Pain Medications Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Pain Medications Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Pain Medications Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Pain Medications Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Pain Medications Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Pain Medications Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Pain Medications Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Prescription Pain Medications Product Offerings
Table 48. Pfizer Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Prescription Pain Medications Product Offerings
Table 52. GSK Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Grunenthal Company Summary
Table 55. Grunenthal Prescription Pain Medications Product Offerings
Table 56. Grunenthal Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Grunenthal Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Prescription Pain Medications Product Offerings
Table 60. Bayer Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Prescription Pain Medications Product Offerings
Table 64. Sanofi Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Prescription Pain Medications Product Offerings
Table 68. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Prescription Pain Medications Product Offerings
Table 72. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Endo Company Summary
Table 75. Endo Prescription Pain Medications Product Offerings
Table 76. Endo Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Endo Key News & Latest Developments
Table 78. Merck Company Summary
Table 79. Merck Prescription Pain Medications Product Offerings
Table 80. Merck Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Merck Key News & Latest Developments
Table 82. Depomed Company Summary
Table 83. Depomed Prescription Pain Medications Product Offerings
Table 84. Depomed Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Depomed Key News & Latest Developments
Table 86. Teva Company Summary
Table 87. Teva Prescription Pain Medications Product Offerings
Table 88. Teva Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Teva Key News & Latest Developments
Table 90. J&J Company Summary
Table 91. J&J Prescription Pain Medications Product Offerings
Table 92. J&J Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. J&J Key News & Latest Developments
Table 94. Allergan Company Summary
Table 95. Allergan Prescription Pain Medications Product Offerings
Table 96. Allergan Prescription Pain Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Allergan Key News & Latest Developments
Table 98. Prescription Pain Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Prescription Pain Medications Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Prescription Pain Medications Production by Region, 2018-2023 (K Units)
Table 101. Global Prescription Pain Medications Production by Region, 2024-2029 (K Units)
Table 102. Prescription Pain Medications Market Opportunities & Trends in Global Market
Table 103. Prescription Pain Medications Market Drivers in Global Market
Table 104. Prescription Pain Medications Market Restraints in Global Market
Table 105. Prescription Pain Medications Raw Materials
Table 106. Prescription Pain Medications Raw Materials Suppliers in Global Market
Table 107. Typical Prescription Pain Medications Downstream
Table 108. Prescription Pain Medications Downstream Clients in Global Market
Table 109. Prescription Pain Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Pain Medications Segment by Type in 2022
Figure 2. Prescription Pain Medications Segment by Application in 2022
Figure 3. Global Prescription Pain Medications Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Pain Medications Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Pain Medications Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Pain Medications Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Pain Medications Revenue in 2022
Figure 9. By Type - Global Prescription Pain Medications Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Pain Medications Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Pain Medications Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Prescription Pain Medications Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Pain Medications Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Pain Medications Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Prescription Pain Medications Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Pain Medications Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Pain Medications Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Pain Medications Sales Market Share, 2018-2029
Figure 23. US Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Pain Medications Sales Market Share, 2018-2029
Figure 28. Germany Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Pain Medications Sales Market Share, 2018-2029
Figure 37. China Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Pain Medications Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Pain Medications Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Pain Medications Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Pain Medications Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Pain Medications Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Pain Medications by Region, 2022 VS 2029
Figure 54. Prescription Pain Medications Industry Value Chain
Figure 55. Marketing Channels

※参考情報

処方鎮痛薬は、痛みを軽減または遮断するために医師が認可した薬品であり、主に中等度から重度の痛みを管理するために使用されます。痛みは様々な原因によって引き起こされ、その性質や持続時間も多岐にわたります。そのため、処方鎮痛薬は、その作用機序や使用目的に応じて多くの種類が存在し、患者の個別のニーズに応じた適切な選択が求められます。

まず、処方鎮痛薬の定義についてですが、これは医師の診断に基づいて処方される薬品であり、自己判断や自己流による使用が推奨されないことが特徴です。一般的に、痛みの程度や種類に応じて適切な薬が選ばれ、患者一人ひとりに合わせた治療が行われます。このため、処方鎮痛薬には医師の監督が必須であり、患者の健康状態や他の治療法との相互作用を考慮して処方されます。

処方鎮痛薬はその主に以下のような種類に分類されます。まず、非オピオイド鎮痛薬には、アセトアミノフェンや非ステロイド抗炎症薬（NSAIDs）が含まれます。アセトアミノフェンは、発熱の軽減にも使われる一般的な鎮痛剤で、胃の負担が少ないため比較的安全に使用できます。NSAIDsは、炎症を抑える効果もあるため、特に炎症に関連する痛み（例えば、関節炎や筋肉痛）に対して有効です。しかし、これらの薬剤も肝臓や腎臓に負担をかける可能性があるため、用量や使用期間に注意が必要です。

次に、オピオイド鎮痛薬は、中等度から重度の痛みを強力に軽減するために使用されます。モルヒネやオキシコドン、フentanylなどが代表的なオピオイド薬です。これらは脳の痛みを認識する部位に作用し、痛みを感じにくくしますが、依存症のリスクや副作用（便秘、抑うつ、呼吸抑制など）もあります。このため、オピオイドは通常、短期間の使用に限られ、他の治療法と併用されることが一般的です。

さらに、鎮痛目的で使用される他の薬剤としては、抗うつ薬や抗けいれん薬もあります。これらの薬は、神経を介した痛みを軽減する効果を持っており、特に神経障害性疼痛（帯状疱疹後神経痛や糖尿病性神経障害など）に対して有効です。抗うつ薬としては、例えばデュロキセチンが有名で、神経伝達物質のセロトニンやノルエピネフリンの再吸収を阻害することで、痛みの閾値を上げ、痛みの感受性を減少させます。

処方鎮痛薬の用途は、さまざまな痛みの緩和に広がっており、手術後の疼痛管理、慢性的な痛み（例えば、がん性疼痛や慢性腰痛）、急性の外傷後の痛み、あるいは緩和ケアにおける痛みの管理など、非常に多岐にわたります。痛みの種類に応じて適切な鎮痛薬を選ぶことは、患者の生活の質を大きく向上させる要因となります。その際には、痛みの程度、痛みの原因、患者の全体的な健康状態、過去の病歴、さらには他の薬剤との相互作用など、多くの要素を考慮に入れる必要があります。

近年では、薬物療法のみならず、非薬物的アプローチも併用されることが増えており、物理療法や心理的支援、鍼治療、あるいは認知行動療法などが提案されています。これにより、患者の痛みの管理はより包括的かつ多角的なアプローチへと進化しています。

また、処方鎮痛薬の関連技術についても触れておきます。例えば、患者の痛みをより的確に評価するためのテクノロジーが発展してきています。痛みの強さや性質を数値化するための尺度や、AIを活用した痛みの分析システムなどが実用化されつつあり、これにより個別化医療が進む可能性があります。こうした技術革新は、患者の痛みの長期的な管理や治療効果の評価において重要な役割を果たすでしょう。

処方鎮痛薬の使用には、その利点だけでなくリスクも伴うため、医療従事者による厳密な管理が求められます。特にオピオイドに関しては、近年の過剰処方や乱用問題もあり、安全な使用を促す取り組みが進められています。患者に対しては、薬の使い方や効果、副作用について詳細な説明が行われ、必要に応じて定期的なフォローアップが実施されることが望まれます。

最後に、処方鎮痛薬の処方管理は患者の健康だけでなく、医療システム全体の健全性にも影響を与えます。適切な鎮痛治療が行われることで、患者の痛みが軽減され、生活の質が向上し、結果的に医療費の削減にもつながると考えられます。したがって、医療従事者、患者、そして社会全体が協力して、より効果的で安全な痛みの管理を目指すことが重要です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 処方鎮痛薬の世界市場見通し2023年-2029年(Prescription Pain Medications Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

処方鎮痛薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp